Pfizer, deCODE genetics collaborate to discover sequence variants linked with SLE

September 07, 2017

The new nCounter Digital Analyzer has a throughput that is 50% greater than the first generation system, allowing researchers to more quickly process studies of hundreds or thousands of samples. Along with the second generation system, NanoString is introducing the nSolver?? software package that allows users to quickly and easily quality control, normalize and analyze their large nCounter data, and transfer results to third party software packages for data visualization or cross platform analysis. The new nCounter Analysis System is manufactured under ISO 13485 and GMP, the quality standards typical of in vitro diagnostic (IVD) platforms. The second generation system includes the hardware upon which the company will pursue regulatory clearance for its NanoString Breast Cancer Intrinsic Subtyping Assay and other molecular diagnostic assays.

Brad Gray, President and CEO of NanoString Technologies, commented: "The nCounter system is ideal for large-scale pathway-based translational research and for the validation of Next Generation Sequencing results. The enhanced features introduced today will help ensure our customers spend even less time generating data, and more time extracting meaning from their studies. In addition, the introduction of IVD-quality hardware is an important milestone along our path of developing nCounter-based molecular diagnostics."

Source: NanoString Technologies, Inc.